Search research articles
Contact Us
Filters
Showing results (11-20 of 236) with videos related to
Page
of 24
Sort By:
Current Opinion in Pharmacology
|
August 5, 2008
Targeting insulin and insulin-like growth factor signalling in oncology
Michael Pollak
Best Practice & Research. Clinical Endocrinology & Metabolism
|
October 31, 2008
Insulin, insulin-like growth factors and neoplasia
Michael Pollak
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 5, 2012
The insulin receptor/insulin-like growth factor receptor family as a therapeutic target in oncology
Michael Pollak
Nature Medicine
|
June 6, 2014
Overcoming Drug Development Bottlenecks With Repurposing: Repurposing biguanides to target energy metabolism for cancer treatment
Michael Pollak
Cancer Cell
|
March 23, 2013
Targeting oxidative phosphorylation: why, when, and how
Michael Pollak
The New York Times on the Web
|
October 20, 2001
Doctors fighting backlash over vaccines
Michael Pollak
Nature Reviews. Cancer
|
February 17, 2012
The insulin and insulin-like growth factor receptor family in neoplasia: an update
Michael Pollak
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 15, 2005
Individualizing interventions for cancer prevention
Michael Pollak
Cancer Prevention Research (Philadelphia, Pa.)
|
September 3, 2010
Metformin and other biguanides in oncology: advancing the research agenda
Michael Pollak
The Lancet. Oncology
|
May 18, 2010
Beyond steroid hormones: the new cancer endocrinology
Michael Pollak
Page
of 24
Search research articles
Search
Showing results (11-20 of 236) with videos related to
Sort By:
Page
of 24
Current Opinion in Pharmacology
|
August 5, 2008
Targeting insulin and insulin-like growth factor signalling in oncology
Michael Pollak
Best Practice & Research. Clinical Endocrinology & Metabolism
|
October 31, 2008
Insulin, insulin-like growth factors and neoplasia
Michael Pollak
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 5, 2012
The insulin receptor/insulin-like growth factor receptor family as a therapeutic target in oncology
Michael Pollak
Nature Medicine
|
June 6, 2014
Overcoming Drug Development Bottlenecks With Repurposing: Repurposing biguanides to target energy metabolism for cancer treatment
Michael Pollak
Cancer Cell
|
March 23, 2013
Targeting oxidative phosphorylation: why, when, and how
Michael Pollak
The New York Times on the Web
|
October 20, 2001
Doctors fighting backlash over vaccines
Michael Pollak
Nature Reviews. Cancer
|
February 17, 2012
The insulin and insulin-like growth factor receptor family in neoplasia: an update
Michael Pollak
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 15, 2005
Individualizing interventions for cancer prevention
Michael Pollak
Cancer Prevention Research (Philadelphia, Pa.)
|
September 3, 2010
Metformin and other biguanides in oncology: advancing the research agenda
Michael Pollak
The Lancet. Oncology
|
May 18, 2010
Beyond steroid hormones: the new cancer endocrinology
Michael Pollak
Page
of 24